Exercise Post-Diagnosis of Breast Cancer
Launched by UNIVERSITY OF HAWAII · Jul 8, 2019
Trial Information
Current as of April 25, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a 12-week exercise program can change the body composition of women who have recently been diagnosed with breast cancer. The study aims to understand not only how exercise might help improve physical health during treatment but also what factors encourage women to stay physically active even after the program ends.
To participate, women must have been diagnosed with breast cancer within the last two years and may be undergoing treatments like surgery or chemotherapy. They should also be able to lie flat for a short period and stand without help. Participants will attend scheduled exercise sessions and complete some questionnaires about their experiences. This study is currently recruiting, so if you or someone you know fits the criteria and is interested, it might be a great opportunity to contribute to important research while also focusing on health and wellness during a challenging time.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • New diagnosis of breast cancer (within the past 2 years, any subtype, stage I-III)
- • Can be undergoing neo/adjuvant treatment (surgery, chemotherapy, radiation or endocrine therapy)
- • Participant is willing and able to comply with the protocol for the duration of the study including undergoing scheduled exercise sessions, completing questionnaires and biometric/biomarker studies
- • Participant must be able to lie flat on their back for up to 10 minutes
- • Participant must be able to stand without aid for at least 2 minutes
- Exclusion Criteria:
- • Participant with breast cancer recurrence
- • Metastatic breast cancer
- • Uncontrolled psychiatric disorder that can affect self-assessment
- • Pregnant patient
- • Participants with any internal artifact (e.g. pacemakers, internal fixation, arthroplasty) or other physical impairment that would alter the body composition assessment
About University Of Hawaii
The University of Hawaii is a leading research institution committed to advancing medical science and improving health outcomes through innovative clinical trials. With a diverse team of experienced researchers and access to a wide range of resources, the university fosters collaborative initiatives that aim to address pressing health challenges. By integrating cutting-edge technology and multidisciplinary expertise, the University of Hawaii conducts rigorous clinical research to enhance understanding of various medical conditions, ultimately contributing to the development of effective therapies and interventions for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Honolulu, Hawaii, United States
Patients applied
Trial Officials
Jami Fukui, MD
Principal Investigator
University of Hawaii Cancer Research Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials